Current Trends and Transitions in Alzheimer’s Disease: Implications for Clinical Practice

online

Disease modification remains the ultimate target of Alzheimer’s disease (AD) research. Just in the past year, the entire Alzheimer’s clinical and research field has been revitalized based on clinical trial ...

Disease modification remains the ultimate target of Alzheimer’s disease (AD) research. Just in the past year, the entire Alzheimer’s clinical and research field has been revitalized based on clinical trial data supporting the potential role of anti-amyloid therapies in AD. This revitalization has brought to the fore the critical importance of early clinical detection of mild cognitive impairment (MCI) due to AD and mild AD dementia, understanding the role of Abeta in the pathogenesis of AD, and the continuously evolving role of biomarkers in the diagnosis of AD.

---

Write the first review

Resource tags